Epstein-Barr virus encoded miR-BART11 promotes inflammationinduced carcinogenesis by targeting FOXP1

Oncotarget

Volumn 7, Issue 24, 2016, Pages 36783-36799

  Song, Yali ^a,b   Li, Xiaoling ^a,b   Zeng, Zhaoyang ^a,b   Li, Qiao ^b   Gong, Zhaojian ^b   Liao, Qianjin ^b   Li, Xiayu ^b   Chen, Pan ^b   Xiang, Bo ^a,b   Zhang, Wenling ^b   Xiong, Fang ^a   Zhou, Yanhong ^b   Zhou, Ming ^b   Ma, Jian ^b   Li, Yong ^b,c   Chen, Xiang ^a   Li, Guiyuan ^a,b   Xiong, Wei ^a,b  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b CENTRAL SOUTH UNIVERSITY   (China)

^c LERNER RESEARCH INSTITUTE   (United States)

Author keywords

EBV miR BART11; Epstein Barr virus; FOXP1; Gastric cancer; Nasopharyngeal carcinoma

Indexed keywords

BART11 PROTEIN; FORKHEAD TRANSCRIPTION FACTOR; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; MESSENGER RNA; MICRORNA; TRANSCRIPTION FACTOR FOXP1; TRANSCRIPTION FACTOR RELA; UNCLASSIFIED DRUG; VIRUS PROTEIN; FOXP1 PROTEIN, HUMAN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MIR-BART11, EPSTEIN-BARR VIRUS; REPRESSOR PROTEIN; VIRUS RNA;

3' UNTRANSLATED REGION; ARTICLE; CANCER CELL; CANCER INHIBITION; CARCINOGENESIS; CELL DIFFERENTIATION; CELL INFILTRATION; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE RELEASE; EPSTEIN BARR VIRUS; GENE OVEREXPRESSION; GENE REGULATORY NETWORK; HUMAN; HUMAN CELL; INFLAMMATION; INFLAMMATORY CELL; LUCIFERASE ASSAY; MACROPHAGE; MONOCYTE; NASOPHARYNX CARCINOMA; PREDICTION; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN TARGETING; SIGNAL TRANSDUCTION; STOMACH CANCER; TUMOR ASSOCIATED LEUKOCYTE; TUMOR MICROENVIRONMENT; COMPLICATION; EPSTEIN BARR VIRUS INFECTION; GENE EXPRESSION REGULATION; GENETICS; HOST PATHOGEN INTERACTION; METABOLISM; NASOPHARYNX TUMOR; PHYSIOLOGY; RNA INTERFERENCE; STOMACH TUMOR; TUMOR CELL LINE; VIROLOGY;

3' UNTRANSLATED REGIONS; CARCINOGENESIS; CELL LINE, TUMOR; CELL PROLIFERATION; EPSTEIN-BARR VIRUS INFECTIONS; FORKHEAD TRANSCRIPTION FACTORS; GENE EXPRESSION REGULATION, NEOPLASTIC; HERPESVIRUS 4, HUMAN; HOST-PATHOGEN INTERACTIONS; HUMANS; INFLAMMATION; MICRORNAS; NASOPHARYNGEAL NEOPLASMS; NF-KAPPA B; REPRESSOR PROTEINS; RNA INTERFERENCE; RNA, VIRAL; STOMACH NEOPLASMS;

EID: 84978040300     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.9170     Document Type: Article

References (81)

1. Xiong W, Zeng ZY, Xia JH, Xia K, Shen SR, Li XL, Hu DX, Tan C, Xiang JJ, Zhou J, Deng H, Fan SQ, Li WF, et al. A susceptibility locus at chromosome 3p21 linked to familial nasopharyngeal carcinoma. Cancer Res. 2004; 64:1972-1974.
2. Zeng Z, Huang H, Zhang W, Xiang B, Zhou M, Zhou Y, Ma J, Yi M, Li X, Xiong W and Li G. Nasopharyngeal carcinoma: advances in genomics and molecular genetics. Sci China Life Sci. 2011; 54:966-975.
3. Zhou HD, Li GY, Yang YX, Li XL, Sheng SR, Zhang WL and Zhao J. Intracellular co-localization of SPLUNC1 protein with nanobacteria in nasopharyngeal carcinoma epithelia HNE1 cells depended on the bactericidal permeability increasing protein domain. Mol Immunol. 2006; 43:1864-1871.
4. Song X, Chen HX, Wang XY, Deng XY, Xi YX, He Q, Peng TL, Chen J, Chen W, Wong BC and Chen MH. H. pylori-encoded CagA disrupts tight junctions and induces invasiveness of AGS gastric carcinoma cells via Cdx2-dependent targeting of Claudin-2. Cell Immunol. 2013; 286:22-30.
5. Liao Q, Zeng Z, Guo X, Li X, Wei F, Zhang W, Chen P, Liang F, Xiang B, Ma J, Wu M, Tang H, Deng M, et al. LPLUNC1 suppresses IL-6-induced nasopharyngeal carcinoma cell proliferation via inhibiting the Stat3 activation. Oncogene. 2014; 33:2098-2109.
6. Zhou Y, Liao Q, Li X, Wang H, Wei F, Chen J, Yang J, Zeng Z, Guo X, Chen P, Zhang W, Tang K, Li X, Xiong W and Li G. HYOU1, Regulated by LPLUNC1, Is Up-Regulated in Nasopharyngeal Carcinoma and Associated with Poor Prognosis. J Cancer. 2016; 7:367-376.
7. Zheng H, Li M, Ren W, Zeng L, Liu HD, Hu D, Deng X, Tang M, Shi Y, Gong J and Cao Y. Expression and secretion of immunoglobulin alpha heavy chain with diverse VDJ recombinations by human epithelial cancer cells. Mol Immunol. 2007; 44:2221-2227.
8. Duan Z, Zheng H, Xu S, Jiang Y, Liu H, Li M, Hu D, Li W, Bode AM, Dong Z and Cao Y. Activation of the Ig Ialpha1 promoter by the transcription factor Ets-1 triggers Ig Ialpha1-Calpha1 germline transcription in epithelial cancer cells. Cell Mol Immunol. 2014; 11:197-205.
9. Liao Q, Guo X, Li X, Chen P, Liang F, Tang H, Deng M, Wu M, Ma J, Xiong W and Li G. Analysis of the contribution of nasopharyngeal epithelial cancer cells to the induction of a local inflammatory response. J Cancer Res Clin Oncol. 2012; 138:57-64.
10. Yang Y, Zhou H, Li W, Zhou M, Zeng Z, Xiong W, Wu M, Huang H, Zhou Y, Peng C, Huang C, Li X and Li G. Lipopolysaccharide (LPS) regulates TLR4 signal transduction in nasopharynx epithelial cell line 5-8F via NFkappaB and MAPKs signaling pathways. Mol Immunol. 2007; 44:984-992.
11. Zheng H, Li LL, Hu DS, Deng XY and Cao Y. Role of Epstein-Barr virus encoded latent membrane protein 1 in the carcinogenesis of nasopharyngeal carcinoma. Cell Mol Immunol. 2007; 4:185-196.
12. Zeng Z, Fan S, Zhang X, Li S, Zhou M, Xiong W, Tan M, Zhang W and Li G. Epstein-Barr virus-encoded small RNA 1 (EBER-1) could predict good prognosis in nasopharyngeal carcinoma. Clin Transl Oncol. 2016; 18:206-211.
13. Xiao K, Yu Z, Li X, Li X, Tang K, Tu C, Qi P, Liao Q, Chen P, Zeng Z, Li G and Xiong W. Genome-wide Analysis of Epstein-Barr Virus (EBV) Integration and Strain in C666-1 and Raji Cells. J Cancer. 2016; 7:214-224.
14. Barth S, Meister G and Grasser FA. EBV-encoded miRNAs. Biochim Biophys Acta. 2011; 1809:631-640.
15. Chen SJ, Chen GH, Chen YH, Liu CY, Chang KP, Chang YS and Chen HC. Characterization of Epstein-Barr virus miRNAome in nasopharyngeal carcinoma by deep sequencing. PLoS One. 2010; 5.
16. Pfeffer S, Zavolan M, Grasser FA, Chien M, Russo JJ, Ju J, John B, Enright AJ, Marks D, Sander C and Tuschl T. Identification of virus-encoded microRNAs. Science. 2004; 304:734-736.
17. Ramakrishnan R, Donahue H, Garcia D, Tan J, Shimizu N, Rice AP and Ling PD. Epstein-Barr virus BART9 miRNA modulates LMP1 levels and affects growth rate of nasal NK T cell lymphomas. PLoS One. 2011; 6:e27271.
18. Kim do N, Chae HS, Oh ST, Kang JH, Park CH, Park WS, Takada K, Lee JM, Lee WK and Lee SK. Expression of viral microRNAs in Epstein-Barr virus-associated gastric carcinoma. J Virol. 2007; 81:1033-1036.
19. Xie YJ, Long ZF and He XS. Involvement of EBV-encoded BART-miRNAs and dysregulated cellular miRNAs in nasopharyngeal carcinoma genesis. Asian Pac J Cancer Prev. 2013; 14:5637-5644.
20. Yang HJ, Huang TJ, Yang CF, Peng LX, Liu RY, Yang GD, Chu QQ, Huang JL, Liu N, Huang HB, Zhu ZY, Qian CN and Huang BJ. Comprehensive profiling of Epstein-Barr virus-encoded miRNA species associated with specific latency types in tumor cells. Virol J. 2013; 10:314.
21. Yan Q, Zeng Z, Gong Z, Zhang W, Li X, He B, Song Y, Li Q, Zeng Y, Liao Q, Chen P, Shi L, Fan S, Xiang B, Ma J, Zhou M, et al. EBV-miR-BART10-3p facilitates epithelialmesenchymal transition and promotes metastasis of nasopharyngeal carcinoma by targeting BTRC. Oncotarget. 2015; 6:41766-41782. doi: 10.18632/oncotarget.6155.
22. Zeng Z, Huang H, Huang L, Sun M, Yan Q, Song Y, Wei F, Bo H, Gong Z, Zeng Y, Li Q, Zhang W, Li X, et al. Regulation network and expression profiles of Epstein-Barr virus-encoded microRNAs and their potential target host genes in nasopharyngeal carcinomas. Sci China Life Sci. 2014; 57:315-326.
23. Barth S, Pfuhl T, Mamiani A, Ehses C, Roemer K, Kremmer E, Jaker C, Hock J, Meister G and Grasser FA. Epstein-Barr virus-encoded microRNA miR-BART2 downregulates the viral DNA polymerase BALF5. Nucleic Acids Res. 2008; 36:666-675.
24. Lo AK, To KF, Lo KW, Lung RW, Hui JW, Liao G and Hayward SD. Modulation of LMP1 protein expression by EBV-encoded microRNAs. Proc Natl Acad Sci U S A. 2007; 104:16164-16169.
25. Lung RW, Tong JH, Sung YM, Leung PS, Ng DC, Chau SL, Chan AW, Ng EK, Lo KW and To KF. Modulation of LMP2A expression by a newly identified Epstein-Barr virus-encoded microRNA miR-BART22. Neoplasia. 2009; 11:1174-1184.
26. Nachmani D, Stern-Ginossar N, Sarid R and Mandelboim O. Diverse herpesvirus microRNAs target the stressinduced immune ligand MICB to escape recognition by natural killer cells. Cell Host Microbe. 2009; 5:376-385.
27. Cai LM, Lyu XM, Luo WR, Cui XF, Ye YF, Yuan CC, Peng QX, Wu DH, Liu TF, Wang E, Marincola FM, Yao KT, Fang WY, Cai HB and Li X. EBV-miR-BART7-3p promotes the EMT and metastasis of nasopharyngeal carcinoma cells by suppressing the tumor suppressor PTEN. Oncogene. 2014; 34:2156-2166.
28. Choi H, Lee H, Kim SR, Gho YS and Lee SK. Epstein-Barr virus-encoded microRNA BART15-3p promotes cell apoptosis partially by targeting BRUCE. J Virol. 2013; 87:8135-8144.
29. Choy EY, Siu KL, Kok KH, Lung RW, Tsang CM, To KF, Kwong DL, Tsao SW and Jin DY. An Epstein-Barr virusencoded microRNA targets PUMA to promote host cell survival. J Exp Med. 2008; 205:2551-2560.
30. Ye Y, Zhou Y, Zhang L, Chen Y, Lyu X, Cai L, Lu Y, Deng Y, Wang J, Yao K, Fang W, Cai H and Li X. EBV-miRBART1 is involved in regulating metabolism-associated genes in nasopharyngeal carcinoma. Biochem Biophys Res Commun. 2013; 436:19-24.
31. Zeng ZY, Zhou YH, Zhang WL, Xiong W, Fan SQ, Li XL, Luo XM, Wu MH, Yang YX, Huang C, Cao L, Tang K, Qian J, Shen SR and Li GY. Gene expression profiling of nasopharyngeal carcinoma reveals the abnormally regulated Wnt signaling pathway. Hum Pathol. 2007; 38:120-133.
32. Zeng Z, Zhou Y, Xiong W, Luo X, Zhang W, Li X, Fan S, Cao L, Tang K, Wu M and Li G. Analysis of gene expression identifies candidate molecular markers in nasopharyngeal carcinoma using microdissection and cDNA microarray. J Cancer Res Clin Oncol. 2007; 133:71-81.
33. Zhang W, Zeng Z, Zhou Y, Xiong W, Fan S, Xiao L, Huang D, Li Z, Li D, Wu M, Li X, Shen S, Wang R, Cao L, Tang K and Li G. Identification of aberrant cell cycle regulation in Epstein-Barr virus-associated nasopharyngeal carcinoma by cDNA microarray and gene set enrichment analysis. Acta Biochim Biophys Sin (Shanghai). 2009; 41:414-428.
34. Shi C, Sakuma M, Mooroka T, Liscoe A, Gao H, Croce KJ, Sharma A, Kaplan D, Greaves DR, Wang Y and Simon DI. Down-regulation of the forkhead transcription factor Foxp1 is required for monocyte differentiation and macrophage function. Blood. 2008; 112:4699-4711.
35. Shi C, Zhang X, Chen Z, Sulaiman K, Feinberg MW, Ballantyne CM, Jain MK and Simon DI. Integrin engagement regulates monocyte differentiation through the forkhead transcription factor Foxp1. J Clin Invest. 2004; 114:408-418.
36. Hanahan D and Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011; 144:646-674.
37. Sica A, Larghi P, Mancino A, Rubino L, Porta C, Totaro MG, Rimoldi M, Biswas SK, Allavena P and Mantovani A. Macrophage polarization in tumour progression. Semin Cancer Biol. 2008; 18:349-355.
38. Shimakage M and Sakamoto H. Macrophage involvement in Epstein-Barr virus-related tumors. Exp Ther Med. 2010; 1:285-291.
39. Coussens LM and Werb Z. Inflammation and cancer. Nature. 2002; 420:860-867.
40. Ding SZ and Zheng PY. Helicobacter pylori infection induced gastric cancer; advance in gastric stem cell research and the remaining challenges. Gut pathogens. 2012; 4:18.
41. Howlader N, Ries LA, Mariotto AB, Reichman ME, Ruhl J and Cronin KA. Improved estimates of cancer-specific survival rates from population-based data. Journal of the National Cancer Institute. 2010; 102:1584-1598.
42. Peek RM, Jr. and Crabtree JE. Helicobacter infection and gastric neoplasia. The Journal of pathology. 2006; 208:233-248.
43. Oshima H and Oshima M. The inflammatory network in the gastrointestinal tumor microenvironment: lessons from mouse models. J Gastroenterol. 2012; 47:97-106.
44. Lamouille S, Xu J and Derynck R. Molecular mechanisms of epithelial-mesenchymal transition. Nat Rev Mol Cell Biol. 2014; 15:178-196.
45. Mantovani A, Allavena P, Sica A and Balkwill F. Cancerrelated inflammation. Nature. 2008; 454:436-444.
46. Talbot LJ, Bhattacharya SD and Kuo PC. Epithelialmesenchymal transition, the tumor microenvironment, and metastatic behavior of epithelial malignancies. Int J Biochem Mol Biol. 2012; 3:117-136.
47. Banham AH, Beasley N, Campo E, Fernandez PL, Fidler C, Gatter K, Jones M, Mason DY, Prime JE, TrougouboffP, Wood K and Cordell JL. The FOXP1 winged helix transcription factor is a novel candidate tumor suppressor gene on chromosome 3p. Cancer Res. 2001; 61:8820-8829.
48. Birkenkamp KU and Coffer PJ. FOXO transcription factors as regulators of immune homeostasis: molecules to die for? J Immunol. 2003; 171:1623-1629.
49. Jonsson H and Peng SL. Forkhead transcription factors in immunology. Cellular and molecular life sciences. 2005; 62:397-409.
50. Peng SL. Foxo in the immune system. Oncogene. 2008; 27:2337-2344.
51. Yang XF. Factors regulating apoptosis and homeostasis of CD4+ CD25(high) FOXP3+ regulatory T cells are new therapeutic targets. Frontiers in bioscience. 2008; 13:1472-1499.
52. Deng L, Jing N, Tan G, Zhou M, Zhan F, Xie Y, Cao L and Li G. A common region of allelic loss on chromosome region 3p25.3-26.3 in nasopharyngeal carcinoma. Genes Chromosomes Cancer. 1998; 23:21-25.
53. Lo KW, Teo PM, Hui AB, To KF, Tsang YS, Chan SY, Mak KF, Lee JC and Huang DP. High resolution allelotype of microdissected primary nasopharyngeal carcinoma. Cancer Res. 2000; 60:3348-3353.
54. Shao JY, Wang HY, Huang XM, Feng QS, Huang P, Feng BJ, Huang LX, Yu XJ, Li JT, Hu LF, Ernberg I and Zeng YX. Genome-wide allelotype analysis of sporadic primary nasopharyngeal carcinoma from southern China. Int J Oncol. 2000; 17:1267-1275.
55. Ng CC, Yew PY, Puah SM, Krishnan G, Yap LF, Teo SH, Lim PV, Govindaraju S, Ratnavelu K, Sam CK, Takahashi A, Kubo M, Kamatani N, Nakamura Y and Mushiroda T. A genome-wide association study identifies ITGA9 conferring risk of nasopharyngeal carcinoma. J Hum Genet. 2009; 54:392-397.
56. Zeng Z, Zhou Y, Zhang W, Li X, Xiong W, Liu H, Fan S, Qian J, Wang L, Li Z, Shen S and Li G. Family-based association analysis validates chromosome 3p21 as a putative nasopharyngeal carcinoma susceptibility locus. Genet Med. 2006; 8:156-160.
57. Hu H, Wang B, Borde M, Nardone J, Maika S, Allred L, Tucker PW and Rao A. Foxp1 is an essential transcriptional regulator of B cell development. Nat Immunol. 2006; 7:819-826.
58. Feng X, Wang H, Takata H, Day TJ, Willen J and Hu H. Transcription factor Foxp1 exerts essential cell-intrinsic regulation of the quiescence of naive T cells. Nat Immunol. 2011; 12:544-550.
59. Xue ZH, Zhao CQ, Chua GL, Tan SW, Tang XY, Wong SC and Tan SM. Integrin alphaMbeta2 clustering triggers phosphorylation and activation of protein kinase C delta that regulates transcription factor Foxp1 expression in monocytes. J Immunol. 2010; 184:3697-3709.
60. Yang Y, Zhou H, Yang Y, Li W, Zhou M, Zeng Z, Xiong W, Wu M, Huang H, Zhou Y, Peng C, Huang C, Li X and Li G. Lipopolysaccharide (LPS) regulates TLR4 signal transduction in nasopharynx epithelial cell line 5-8F via NFkappaB and MAPKs signaling pathways. Mol Immunol. 2007; 44:984-992.
61. Ijichi N, Ikeda K, Horie-Inoue K and Inoue S. FOXP1 and estrogen signaling in breast cancer. Vitam Horm. 2013; 93:203-212.
62. Ijichi N, Shigekawa T, Ikeda K, Horie-Inoue K, Shimizu C, Saji S, Aogi K, Tsuda H, Osaki A, Saeki T and Inoue S. Association of double-positive FOXA1 and FOXP1 immunoreactivities with favorable prognosis of tamoxifentreated breast cancer patients. Horm Cancer. 2012; 3:147-159.
63. Shigekawa T, Ijichi N, Ikeda K, Horie-Inoue K, Shimizu C, Saji S, Aogi K, Tsuda H, Osaki A, Saeki T and Inoue S. FOXP1, an estrogen-inducible transcription factor, modulates cell proliferation in breast cancer cells and 5-year recurrence-free survival of patients with tamoxifen-treated breast cancer. Horm Cancer. 2011; 2:286-297.
64. Feng J, Zhang X, Zhu H, Wang X, Ni S and Huang J. High expression of FoxP1 is associated with improved survival in patients with non-small cell lung cancer. Am J Clin Pathol. 2012; 138:230-235.
65. Yang MH, Lin BR, Chang CH, Chen ST, Lin SK, Kuo MY, Jeng YM, Kuo ML and Chang CC. Connective tissue growth factor modulates oral squamous cell carcinoma invasion by activating a miR-504/FOXP1 signalling. Oncogene. 2011; 31:2401-2411.
66. Hu Z, Zhu L, Gao J, Cai M, Tan M, Liu J and Lin B. Expression of FOXP1 in epithelial ovarian cancer (EOC) and its correlation with chemotherapy resistance and prognosis. Tumour Biol. 2015; 36:7269-7275.
67. Hu Z, Zhu L, Tan M, Cai M, Deng L, Yu G, Liu D, Liu J and Lin B. The expression and correlation between the transcription factor FOXP1 and estrogen receptors in epithelial ovarian cancer. Biochimie. 2015; 109:42-48.
68. Toma MI, Weber T, Meinhardt M, Zastrow S, Grimm MO, Fussel S, Wirth MP and Baretton GB. Expression of the Forkhead transcription factor FOXP1 is associated with tumor grade and Ki67 expression in clear cell renal cell carcinoma. Cancer Invest. 2011; 29:123-129.
69. Wan L, Huang J, Chen J, Wang R, Dong C, Lu S and Wu X. Expression and significance of FOXP1, HIF-1α and VEGF in renal clear cell carcinoma. J BUON. 2015; 20:188-195.
70. Zhang Y, Zhang S, Wang X, Liu J, Yang L, He S, Chen L and Huang J. Prognostic significance of FOXP1 as an oncogene in hepatocellular carcinoma. J Clin Pathol. 2012; 65:528-533.
71. Banham AH, Boddy J, Launchbury R, Han C, Turley H, Malone PR, Harris AL and Fox SB. Expression of the forkhead transcription factor FOXP1 is associated both with hypoxia inducible factors (HIFs) and the androgen receptor in prostate cancer but is not directly regulated by androgens or hypoxia. Prostate. 2007; 67:1091-1098.
72. Takayama K, Horie-Inoue K, Ikeda K, Urano T, Murakami K, Hayashizaki Y, Ouchi Y and Inoue S. FOXP1 is an androgen-responsive transcription factor that negatively regulates androgen receptor signaling in prostate cancer cells. Biochem Biophys Res Commun. 2008; 374:388-393.
73. Takayama K, Suzuki T, Tsutsumi S, Fujimura T, Takahashi S, Homma Y, Urano T, Aburatani H and Inoue S. Integrative analysis of FOXP1 function reveals a tumorsuppressive effect in prostate cancer. Mol Endocrinol. 2014; 28:2012-2024.
74. van Keimpema M, Gruneberg LJ, Mokry M, van Boxtel R, Koster J, Coffer PJ, Pals ST and Spaargaren M. FOXP1 directly represses transcription of proapoptotic genes and cooperates with NF-kappaB to promote survival of human B cells. Blood. 2014; 124:3431-3440.
75. Mraz M, Chen L, Rassenti LZ, Ghia EM, Li H, Jepsen K, Smith EN, Messer K, Frazer KA and Kipps TJ. miR-150 influences B-cell receptor signaling in chronic lymphocytic leukemia by regulating expression of GAB1 and FOXP1. Blood. 2014; 124:84-95.
76. Brown PJ, Ashe SL, Leich E, Burek C, Barrans S, Fenton JA, Jack AS, Pulford K, Rosenwald A and Banham AH. Potentially oncogenic B-cell activation-induced smaller isoforms of FOXP1 are highly expressed in the activated B cell-like subtype of DLBCL. Blood. 2008; 111:2816-2824.
77. Wang B, Lin D, Li C and Tucker P. Multiple domains define the expression and regulatory properties of Foxp1 forkhead transcriptional repressors. J Biol Chem. 2003; 278:24259-24268.
78. Zhang W, Zeng Z, Fan S, Wang J, Yang J, Zhou Y, Li X, Huang D, Liang F, Wu M, Tang K, Cao L, Li X, Xiong W and Li G. Evaluation of the prognostic value of TGFbeta superfamily type I receptor and TGF-beta type II receptor expression in nasopharyngeal carcinoma using high-throughput tissue microarrays. J Mol Histol. 2012; 43:297-306.
79. Xu K, Xiong W, Zhou M, Wang H, Yang J, Li X, Chen P, Liao Q, Deng H, Li X, Li G and Zeng Z. Integrating ChIP-sequencing and digital gene expression profiling to identify BRD7 downstream genes and construct their regulating network. Mol Cell Biochem. 2016; 411:57-71.
80. Gong Z, Zhang S, Zeng Z, Wu H, Yang Q, Xiong F, Shi L, Yang J, Zhang W, Zhou Y, Zeng Y, Li X, Xiang B, et al. LOC401317, a p53-regulated long non-coding RNA, inhibits cell proliferation and induces apoptosis in the nasopharyngeal carcinoma cell line HNE2. PLoS One. 2014; 9:e110674.
81. Bo H, Gong Z, Zhang W, Li X, Zeng Y, Liao Q, Chen P, Shi L, Lian Y, Jing Y, Tang K, Li Z, Zhou Y, et al. Upregulated long non-coding RNA AFAP1-AS1 expression is associated with progression and poor prognosis of nasopharyngeal carcinoma. Oncotarget. 2015; 6:20404-20418. doi: 10.18632/oncotarget.4057.